Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4 results found.

Example of search result explained

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2544180
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2544199
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 2544202
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 2553317
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 2553309

Jamteki

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2543036
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2543044

Steqeyma

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2550245
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2550253
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 2558270

Otulfi

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2554283
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2554291
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2554305
Page 1 of 1

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.